search icon
      blog search icon

      MNPR Stock Price History and Quote Analysis: Insights for Investors

      Monopar Therapeutics Inc.



      0.04 (9.88%)

      Open: 1:36 PM

      MNPR Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      MNPR Stock Price Today

      Monopar Therapeutics Inc. (MNPR) stock rallied over 18.88% intraday to trade at $0.4042 a share on NASDAQ. The stock opened with a gain of 19.44% at $0.43 and touched an intraday high of $0.45, rising 12.28% against the last close of $0.36. The Monopar Therapeutics Inc. in stock market went to a low of $0.43 during the session.

      MNPR Stock Snapshot


      Prev. Close

      5.96 Million

      Market Cap


      Day Low




      Number of Shares


      Day High


      P/E ratio


      EPS (TTM)


      Cash Flow per Share


      Free Float in %


      Book Value



      MNPR Stock Price History Chart


      Contact Details

      1000 Skokie Boulevard
      Wilmette, IL 60091


      Contact #:847 388 0349

      Company Information



      Sales or RevenueN/A

      5Y Sales Change0.00%

      Fiscal Year EndsDec. 2022



      About Company

      Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to potentially treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was incorporated in 2014 and is headquartered in Wilmette, Illinois.


      Frequently Asked Questions


      What is the current Monopar Therapeutics Inc. (MNPR) stock price?

      Monopar Therapeutics Inc. (NASDAQ: MNPR) stock price is $0.40 in the last trading session. During the trading session, MNPR stock reached the peak price of $0.45 while $0.43 was the lowest point it dropped to. The percentage change in MNPR stock occurred in the recent session was 18.88% while the dollar amount for the price change in MNPR stock was $0.06.


      MNPR's industry and sector of operation?

      The NASDAQ listed MNPR is part of Biotechnology industry that operates in the broader Healthcare sector. Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.


      Who are the executives of MNPR?

      Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc
      Co-Founder, Chief Executive Officer, Pres & Director
      Ms. Kim R. Tsuchimoto CPA
      Chief Financial Officer, Sec. & Treasurer
      Ms. Kim R. Tsuchimoto CPA
      CFO, Sec. & Treasurer
      Ms. Kim R. Tsuchimoto CPA
      Chief Financial Officer, Sec., Treasurer & Director


      How MNPR did perform over past 52-week?

      MNPR's closing price is 0.01% higher than its 52-week low of $0.427 where as its distance from 52-week high of $4.88 is -0.80%.


      How many employees does MNPR have?

      Number of MNPR employees currently stands at N/A. MNPR operates from 1000 Skokie Boulevard, Wilmette, IL 60091, US.


      Link for MNPR official website?

      Official Website of MNPR is:


      How do I contact MNPR?

      MNPR could be contacted at phone #847 388 0349 and can also be accessed through its website. MNPR operates from 1000 Skokie Boulevard, Wilmette, IL 60091, US.


      How many shares of MNPR are traded daily?

      MNPR stock volume for the day was 278682.00 shares. The average number of MNPR shares traded daily for last 3 months was 952.53 Thousands.


      What is the market cap of MNPR currently?

      The market value of MNPR currently stands at $5.96 Million with its latest stock price at $0.40 and N/A of its shares outstanding.